HIV AIDS: Difference between revisions

Sexually transmitted diseases Main Page
	AIDS Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating AIDS from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
HIV Opportunistic Infections
HIV Coinfections
HIV and Pregnancy
HIV Infection in Infants
Diagnosis
Diagnostic Study of Choice
AIDS Case Definition
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Nutrition
Drug Resistance
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies HIV Vaccine
Case Studies
Case #1
HIV AIDS On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of HIV AIDS All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on HIV AIDS
CDC on HIV AIDS
HIV AIDS in the news
Blogs on HIV AIDS
Directions to Hospitals Treating AIDS
Risk calculators and risk factors for HIV AIDS

	Acquired immunodeficiency syndrome (AIDS);
	The Red ribbon is a symbol for solidarity with HIV-positive people and those living with AIDS.
ICD-10	B24
ICD-9	042
DiseasesDB	5938

VisualWikitext

Revision as of 14:52, 3 June 2012

For AIDS Patient Information click here

For information on Human Immunodeficiency Virus click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

List of abbreviations used in this article

AIDS: Acquired immune deficiency syndrome
HIV: Human immunodeficiency virus
CD4+: T helper cells
CCR5: Chemokine (C-C motif) receptor 5
CDC: Centers for Disease Control and Prevention
WHO: World Health Organization
PCP: Pneumocystis pneumonia
TB: Tuberculosis
MTCT: Mother-to-child transmission
HAART: Highly active antiretroviral therapy
STI/STD: Sexually transmitted infection/disease

Overview

Classification

Comparison between AIDS & HIV

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Prevention & Prophylaxis

Causes

Differentiating AIDS from other Diseases

Natural History, Complications & Prognosis

HIV and its cognitive effects | HIV opportunistic infections

HIV & Coinfections: Tuberculosis and HIV coinfection | HIV and tuberculosis coinfection : drug interaction | HIV coifection with Hepatitis C | Hepatitis B with HIV coinfection | HIV associated nephropathy

Diagnosis

Treatment

Medical Therapy

Pre-exposure prophylaxis | Post-exposure prophylaxis | Medical Therapy | Treatment naive patients | Monitoring during ART

Surgical Therapy

Surgery

Special Topics

Antiretroviral therapy in pregnancy | Importance of nutrition in a HIV/AIDS patient| Cost of therapy

Prevention

Primary Prevention | Secondary Prevention

Treatment Monitoring

Drug Resistance | HIV resistance testing

Landmark Trials/Studies

Guidelines

Related Chapters

External links

Template:Dmoz
"AIDSinfo - HIV/AIDS Treatment Information". US Department of Health and Human Services. Retrieved 2008-03-21.
"UNAIDS: The Joint United Nations Programme on HIV/AIDS". UNAIDS. Retrieved 2008-03-21.

back to top

Template:WH Template:WS

@@ Line 88: / Line 88: @@
 ==[[AIDS landmark trials|Landmark Trials/Studies]]==
 ==Guidelines==
-===Centers for Disease Control and Prevention (CDC)===
-[[AIDS screening#CDC Recommendations for screening for HIV in pregnant women and their infants|Screening HIV pregnant female & infant]] | [[AIDS primary prevention#CDC Recommendations for education and prevention counseling of pregnant women regarding HIV|Counseling of pregnant women]] | [[AIDS medical therapy#Guidelines for initiation of ART|Guidelines for initiation of ART]] | [[Antiretroviral therapy in pregnancy#Recommendations for HIV-Infected pregnant women|Treatment of HIV-Infected pregnant women]] | [[Antiretroviral therapy in pregnancy#Recommendations for Postpartum follow-up of infected women and perinatally exposed children|Postpartum follow-up and treatment]]
-[[HIV prophylaxis#Guidelines for pre-exposure prophlaxis in MSM|Guidelines for pre-exposure prophlaxis in Males having sex with men (MSM)]]
-[[HIV opportunistic infections#Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents|Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents]]
-===National Institute of Health (NIH)===
-====Diagnosis====
-[[AIDS laboratory tests#Laboratory Monitoring Schedule for Patients Prior to and After Initiation of Antiretroviral Therapy|Laboratory Monitoring Schedule for Patients Prior to and After Initiation of Antiretroviral Therapy]] | [[AIDS laboratory tests#CD4 T-Cell Count|CD4 T-Cell Count]] | [[AIDS laboratory tests#Plasma HIV RNA Testing|Plasma HIV RNA Testing]] | [[AIDS laboratory tests#National Institute of Health (NIH) Recommendations for Drug-Resistance Testing|Drug-Resistance Testing]] | [[AIDS laboratory tests#NIH Recommendations for HLA-B*5701 Screening|HLA-B*5701 Screening]] | [[AIDS laboratory tests#NIH Recommendations for Coreceptor Tropism Assays|Coreceptor Tropism Assays]]
-====Treatment====
-'''[[AIDS medical therapy#NIH Recommendations:Treatment-Naive Patients|Treatment-Naive Patients ]]-'''  [[AIDS medical therapy#NIH Recommendations for Initiating Antiretroviral Therapy in Treatment-Naive Patients|Initiating Antiretroviral Therapy]] | [[AIDS medical therapy#What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient|Initial Combination Regimens]]
-'''[[AIDS medical therapy#NIH Recommendations:Treatment-Experienced Patient|Treatment-Experienced Patient]] -''' [[AIDS medical therapy#NIH recommendations for Virologic and Immunologic Failure|Virologic and Immunologic Failure]] | [[AIDS medical therapy#NIH recommendations for Exposure-Response Relationship and Therapeutic Drug Monitoring|Exposure-Response Relationship and Therapeutic Drug Monitoring]]
-'''[[AIDS medical therapy#NIH recommendations for Considerations for Antiretroviral Use in Special Patient Populations|Special Patient Populations]] -''' [[AIDS medical therapy#Special Patient Populations: Acute HIV Infection|Acute HIV Infection]]  | [[AIDS medical therapy#Special Patient Populations: HIV-Infected Women|HIV-Infected Women]] | [[AIDS medical therapy#Special Patient Populations: Older Patient|Older Patient]]
-'''Coinfections -''' [[HIV coinfection with hepatitis b#National Institute of Health recommendations|HIV coinfection with hepatitis b]] | [[HIV coinfection with hepatitis c#National Institute of Health Recommendations|HIV coinfection with hepatitis c]] | [[HIV coinfection with tuberculosis#National Institute of Health Recommendations|HIV coinfection with tuberculosis]] | [[AIDS medical therapy treatment naive patients#A) HIV-associated nephropathy|HIV-associated nephropathy]]
 ==Related Chapters==